Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized Patients

This publication has 14 references indexed in Scilit:

• Initial Low‐Dose Gentamicin forStaphylococcus aureusBacteremia and Endocarditis Is Nephrotoxic
  Clinical Infectious Diseases, 2009
• Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms
  Clinical Infectious Diseases, 2008
• Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity
  Antimicrobial Agents and Chemotherapy, 2008
• Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy
  Journal of Antimicrobial Chemotherapy, 2008
• A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections
  Clinical Infectious Diseases, 2008
• NOVEL EVIDENCE SUGGESTING AN ANTI‐OXIDANT PROPERTY FOR ERYTHROPOIETIN ON VANCOMYCIN‐INDUCED NEPHROTOXICITY IN A RAT MODEL
  Clinical and Experimental Pharmacology and Physiology, 2007
• A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia
  Clinical Therapeutics, 2007
• The Pharmacokinetic and Pharmacodynamic Properties of Vancomycin
  Clinical Infectious Diseases, 2006
• In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: Protection by erdosteine
  Toxicology, 2005
• Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
  Nature Reviews Microbiology, 2004